drugset / Trial / NCT00469404

Single Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID 297307)

NCT00469404 ↗

Phase 1 Terminated 24 enrolled Grünenthal GmbH
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to determine whether the plasma levels of two different analgesic transdermal patch formulations lead to same plasma levels of the active ingredient after single dose application.

Timeline

Start
2007-05
Primary completion
—
Completion
2007-11

Outcome

Outcome not reported

Stopped: “The trial end was achieved according to the definition in the trial protocol”

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — Topical

Indications

No indication recorded.